Systemic-to-pulmonary venous shunt in a haemodialysis patient

A 56-year-old haemodialysis patient was admitted for dysarthriain September 2003. He had been treated by haemodialysis sincethe     

Scattered hyperdense lesions in a haemodialysis patient

Case A 78-year-old man presented with abdominal discomfort and constipationfor several days. He had been receiving regular haemodialysistreatment for 8 months because of     

Bladder cancer in a patient on long-term haemodialysis

We report a case of bladder cancer on long-term haemodialysis. The relationship between bladder cancer and haemodialysis, and the necessity of periodic cytology of bladder washing are discussed.     

Cutaneous ectopic breast calcification in a haemodialysis patient

This case report details the unique breast calcification and swellings of a 61-year-old lady. The ectopic breast calcification was a result of chronic renal failure and hyperparathyroidism secondary to vesiculo-ureteric reflux nephropathy. Subcutaneous nodules were also noted around her ileostomy (from surgery due to Crohn's disease) and abdominal wall. Mammogram revealed calcified breast discs and lobules with extensive vascular calcification. Histological biopsies revealed extensive calcium deposition (benign). Cutaneous deposition of calcium oxalate has been described in 13 patients world wide, usually involving fingers, ears, or nose. Two of these report breast involvement, but this is described as less extensive and more focal calcification on clinical findings and mammography. This case report describes a rare condition with extraordinary mammographic images.     

Ticlopidine induces lupus in a haemodialysis patient.

Sir, It is widely believed that patients on dialysis are immunocompromisedand less commonly afflicted by autoimmune diseases. However,in our dialysis units we often encounter patients with allergiesto particular drugs. Ticlopidine hydrochloride is a plateletaggregation inhibitor, which has been shown to reduce the riskof thrombotic strokes and also is used in the treatment of claudicationand in patients with cardiac stents [1]. Its uncommon but seriousadverse effects are neutropenia, aplastic anaemia, thromboticthrombocytopenic purpura and cholestatic hepatitis – the